ES2268990A1 - Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones. - Google Patents

Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones. Download PDF

Info

Publication number
ES2268990A1
ES2268990A1 ES200502145A ES200502145A ES2268990A1 ES 2268990 A1 ES2268990 A1 ES 2268990A1 ES 200502145 A ES200502145 A ES 200502145A ES 200502145 A ES200502145 A ES 200502145A ES 2268990 A1 ES2268990 A1 ES 2268990A1
Authority
ES
Spain
Prior art keywords
sus
quinónicos
antitumorales
obtención
aplicaciones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200502145A
Other languages
English (en)
Other versions
ES2268990B1 (es
Inventor
Orden Maria Teresa Molina
Honghao Sun
Chamudis Sandra Taliansky
Moya Amancio Carnero
Rodriguez Fernando Blanco
Ocana Maria Victoria Moneo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Centro Nacional de Investigaciones Oncologicas CNIO
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Centro Nacional de Investigaciones Oncologicas CNIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Centro Nacional de Investigaciones Oncologicas CNIO filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES200502145A priority Critical patent/ES2268990B1/es
Priority to PCT/ES2006/000499 priority patent/WO2007026041A2/es
Publication of ES2268990A1 publication Critical patent/ES2268990A1/es
Application granted granted Critical
Publication of ES2268990B1 publication Critical patent/ES2268990B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/24—Quinones containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C07C205/46—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group the carbon skeleton containing carbon atoms of quinone rings
    • C07C205/47—Anthraquinones containing nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/16—Quinones the quinoid structure being part of a condensed ring system containing three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/16—Quinones the quinoid structure being part of a condensed ring system containing three rings
    • C07C50/18—Anthraquinones, i.e. C14H8O2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/16—Quinones the quinoid structure being part of a condensed ring system containing three rings
    • C07C50/20—Quinones the quinoid structure being part of a condensed ring system containing three rings with unsaturation outside the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/34—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos quinónicos antitumorales y sus derivados, procedimiento de obtención y sus aplicaciones. La presente invención describe unos compuestos derivados 1,4-dioxaantracénicos, principalmente 1,4-antraquinónicos, de fórmula general I como inhibidores del crecimiento de células tumorales, así como a procedimientos útiles para su preparación, composiciones farmacéuticas que los contienen y sus aplicaciones clínicas como antitumoral y antiparasitario.
ES200502145A 2005-09-02 2005-09-02 Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones. Expired - Fee Related ES2268990B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200502145A ES2268990B1 (es) 2005-09-02 2005-09-02 Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones.
PCT/ES2006/000499 WO2007026041A2 (es) 2005-09-02 2006-09-01 Compuestos 1,4 antraquinonicos, su procedimiento de obtencion y su aplicacion como antiumorales.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200502145A ES2268990B1 (es) 2005-09-02 2005-09-02 Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones.

Publications (2)

Publication Number Publication Date
ES2268990A1 true ES2268990A1 (es) 2007-03-16
ES2268990B1 ES2268990B1 (es) 2008-04-01

Family

ID=37809234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200502145A Expired - Fee Related ES2268990B1 (es) 2005-09-02 2005-09-02 Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones.

Country Status (2)

Country Link
ES (1) ES2268990B1 (es)
WO (1) WO2007026041A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113372263B (zh) * 2021-05-21 2022-04-19 温州医科大学 一种2-氯-3-胺基萘醌化合物的制备方法
CN113292503B (zh) * 2021-05-22 2022-05-13 台州市第一人民医院 一种2-溴-3-胺基萘醌化合物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006233101B2 (en) * 2005-02-23 2011-09-01 Arbiser, Jack Honokiol derivatives for the treatment of proliferative disorders

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BARRANCO E. y col. Synthesis, electrochemical properties and effect of substituents on p-extended TCNQ and DCNQI systems. Synthetic Metals. 1993, Vol. 56, N‘1, pàginas 1717-20, ISSN: 0379-6779. Pàgina 1719, compuestos 3b y 3e con RN 31619-41-7 y RN 16872-65-4. *
BEDWORTH, P.V. y col. The synthesis of a symmetrically substituted alfa-octa(isopentoxy) anthralocyanine. Chem. Commun. 1997, pàginas 1353-4. Pàgina 1353, esquema 1, compuesto con RN 14681-17-5. *
DEFOIN, A.; RIGAUDY, J. Epoxy ketols from monoreduction with hydrides of 2,3-epoxy-1,4-anthraquinone and its meso-diphenyl derivative. Related chlorohydrins. Bulletin de la SociÉtÉ Chimique de France (1979), (3-4, Pt. 2), pàginas 110-18, ISSN: 0037-8968. Pàgina 110, compuesto 4a con RN 16212-82-1. *
HAMZAH, A.S. y col. New Anthraquinones from the Roots of Hedyotis dichotoma. J. Nat Prod. 1997, Vol. 60, pàginas 36-37. Pàgina 36, compuesto 2. *
HUA D.H. y col. Synthesis and in vitro antitumor activity of substituted anthracene-1,4-diones. Tetrahedron. 2004, Vol. 60, N‘ 45, pàginas 10155-10163, ISSN 0040-4020. Pàgina 10157, compuesto 7 con RN 404351-96-8; pàgina 10156, compuesto 1 con RN 635-12-1. 1. Introduccion; 2.1 Synthesis of substituted 1,4-anthracenediones. *
JIMENEZ, P. y col. Thermochemistry of 9-hydroxy-1,4- anthraquinone and 9-methoxy-1,4-anthraquinone. Journal of Chemical Thermodynamics, 2002, Vol. 34, N‘ 7, pàginas 1117-1126, ISSN: 0021-9614. Pàgina 1118, compuestos a y b con RN 74553-57-4 y RN 60466-75-3. *
KALLMAYER, H.J. y col. Reaction of 1,4-naphtoquinone and 1,4 anthraquinone with N,N-dialkylhydrazines. Pharmazie. 1995, Vol. 50, N‘ 7, pàginas 506-507, ISSN 0031-7144. Pàgina 506, compuestos 8a y 8b con RN 166759-09-7 y RN 166759-07-5. *
SHINGO, M. y col. The structure of cervicarcin. Journal of the American Chemical Society. 1964, Vol. 86, N‘ 20, pàginas 4507-8, ISSN 0002-7863. Pàgina 4508, compuesto XII con RN 1228-86-0. *

Also Published As

Publication number Publication date
ES2268990B1 (es) 2008-04-01
WO2007026041A2 (es) 2007-03-08
WO2007026041A3 (es) 2007-05-03

Similar Documents

Publication Publication Date Title
MX2010003156A (es) Derivados de aril amida substituida con tetrazol y usos de los mismos.
TW200801003A (en) Novel compounds
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
MX339476B (es) Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
MY148634A (en) Pyridazinone derivatives
TW200738659A (en) Novel compounds
MY152283A (en) Polo-like kinase inhibitirs
TW200833326A (en) Chemical compounds 572
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
GB0305152D0 (en) Organic compounds
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
JO2770B1 (en) Organic compounds
TW200833670A (en) Novel compounds 569
TW200745084A (en) Novel compounds
TW200740814A (en) Compounds
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MX2012013274A (es) Novedosos derivados de la pirimidina.
PL1877367T3 (pl) Pochodne acetylenu
TW200745122A (en) New compounds I
TW200635917A (en) Novel compounds

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20070316

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2268990B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180809